儿童人群中的大麻二酚

IF 0.2 4区医学 Q4 PSYCHIATRY Psychiatric Annals Pub Date : 2023-06-01 DOI:10.3928/00485713-20230516-01

M. F. de Almeida, A. Crippa

{"title":"儿童人群中的大麻二酚","authors":"M. F. de Almeida, A. Crippa","doi":"10.3928/00485713-20230516-01","DOIUrl":null,"url":null,"abstract":"\n Recently, there has been significant interest in using cannabidiol (CBD) in the pediatric population. Robust evidence exists for the anticonvulsant action of CBD in some childhood epileptic syndromes, and CBD can reduce anxiety symptoms, stereotyped behavior, hyperactivity, and sleep disorders. However, there are other diseases, such as fragile X syndrome and conditions resulting in intellectual disability, in which CBD use is developing. This article provides the reader with a discussion of the current scientific evidence regarding the use of CBD in the pediatric population.\n \n [\n Psychiatr Ann\n . 2023;53(6):256–258.]\n \n","PeriodicalId":20917,"journal":{"name":"Psychiatric Annals","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cannabidiol in the Pediatric Population\",\"authors\":\"M. F. de Almeida, A. Crippa\",\"doi\":\"10.3928/00485713-20230516-01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n Recently, there has been significant interest in using cannabidiol (CBD) in the pediatric population. Robust evidence exists for the anticonvulsant action of CBD in some childhood epileptic syndromes, and CBD can reduce anxiety symptoms, stereotyped behavior, hyperactivity, and sleep disorders. However, there are other diseases, such as fragile X syndrome and conditions resulting in intellectual disability, in which CBD use is developing. This article provides the reader with a discussion of the current scientific evidence regarding the use of CBD in the pediatric population.\\n \\n [\\n Psychiatr Ann\\n . 2023;53(6):256–258.]\\n \\n\",\"PeriodicalId\":20917,\"journal\":{\"name\":\"Psychiatric Annals\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychiatric Annals\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3928/00485713-20230516-01\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatric Annals","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3928/00485713-20230516-01","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

摘要

最近，在儿科人群中使用大麻二酚(CBD)有很大的兴趣。强有力的证据表明，CBD在一些儿童癫痫综合征中具有抗惊厥作用，CBD可以减轻焦虑症状、刻板行为、多动和睡眠障碍。然而，还有其他疾病，如脆性X染色体综合征和导致智力残疾的疾病，CBD的使用正在增加。这篇文章为读者提供了关于在儿科人群中使用CBD的当前科学证据的讨论。[精神病医生安。]2023; 53(6): 256 - 258。)

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Cannabidiol in the Pediatric Population

Recently, there has been significant interest in using cannabidiol (CBD) in the pediatric population. Robust evidence exists for the anticonvulsant action of CBD in some childhood epileptic syndromes, and CBD can reduce anxiety symptoms, stereotyped behavior, hyperactivity, and sleep disorders. However, there are other diseases, such as fragile X syndrome and conditions resulting in intellectual disability, in which CBD use is developing. This article provides the reader with a discussion of the current scientific evidence regarding the use of CBD in the pediatric population. [ Psychiatr Ann . 2023;53(6):256–258.]

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊